Besides, the cellular platinum accumulation of PPS-ALN-Pt conjugates was higher than that of cisplatin in HeLa cells, implying that the polysaccharide-platinum conjugated polymers might have a synergistically therapeutic application in metal anticancer drug delivery.Advances in nanotheranostics have promoted the development of precision medicine, which has great potential as a weapon for clinical diagnosis and therapy of tumors. However, the combination of three functional principle components (imaging probes, therapeutic agents and surface coating) in traditional theranostic system is difficult to be achieved in only one step, while undergoing multiple synthesis procedures, time-consuming process and unknown toxicity. Herein, we fabricated iodinated polyaniline (LC@I-PANi) nanoparticles via a facile one-step synthesis approach integrating chemical oxidative polymerization and iodine-doping process for computed tomography (CT) imaging and photoacoustic (PA) imaging-guided photothermal therapy (PTT). Iodic acid (HIO3) as an oxidant induces chemical oxidation polymerization of aniline monomers. Meanwhile, iodine is incorporated into the polyaniline structural units in the process of polymerization to obtain LC@I-PANi nanoparticles. Moreover, thel-cysteine (LC) has an effect on diameter of LC@I-PANi nanoparticles, which enables nanoparticles have size-controlled spherical morphology and good colloidal stability.  https://www.selleckchem.com/products/FK-506-(Tacrolimus).html  The hemolysis assay and cytotoxicity assessment verified the good biocompatibility of LC@I-PANi. Moreover, our LC@I-PANi nanoparticles could not only exhibit appealing PTT efficiency, but also achieve excellent CT/PA dual-mode imaging effect. The histological evaluations suggested the negligible toxicity of LC@I-PANi in vivo. This is the first time to our knowledge that multifunctional LC@I-PANi nanoparticles were prepared by an ingenious one-step method. This work not only highlights a one-step strategy that simplified the complex synthesis of LC@I-PANi nanoparticles, but also provides insight for further biomedical application of "all-in-one" theranostic agent.Electrospun nanofibers emulate extracellular matrix (ECM) morphology and architecture; however, small pore size and tightly-packed fibers impede their translation in tissue engineering. Here we exploited in situ gas foaming to afford three-dimensional (3D) poly(L-lactide-co-ε-caprolactone)/silk fibroin (PLCL/SF) scaffolds, which exhibited nanotopographic cues and a multilayered structure. The addition of SF improved the hydrophilicity and biocompatibility of 3D PLCL scaffolds. Three-dimensional scaffolds exhibited larger pore size (38.75 ± 9.78 μm2) and high porosity (87.1% ± 1.5%) than that of their 2D counterparts. 3D scaffolds also improved the deposition of ECM components and neo-vessel regeneration as well as exhibited more numbers of CD163+/CCR7+ cells after 2 weeks implantation in a subcutaneous model. Collectively, 3D PLCL/SF scaffolds have broad implications for regenerative medicine and tissue engineering applications.MXene quantum dots have attracted much attention due to their great optical performance and excellent water solubility. Glutathione (GSH) plays a key role in living cells. In this study, a biocompatibility nanoprobe was prepared for detecting intracellular GSH based on MXene N-Ti3C2 quantum dots (N-Ti3C2 QDs). The N-Ti3C2 QDs act as the fluorescence reporters and the ferric iron (Fe3+) as the quenchers based on nonradiative electron-hole annihilation. When Fe3+ encounters the amino group of N-Ti3C2 QDs, the electrons of N-Ti3C2 QDs in the excited state will transfer to the half-filled 3d orbitals of Fe3+, leading to the fluorescence quenching of N-Ti3C2 QDs. When the N-Ti3C2 QDs/Fe3+ nanoprobe acts on the cancer cell MCF-7, the abundant GSH in the cancer cells can reduce Fe3+ to Fe2+, which will restore the fluorescence of N-Ti3C2 QDs. The N-Ti3C2 QDs/Fe3+ nanoprobe displays a high sensitivity for GSH with a detection limit of 0.17 μM in range of 0.5-100 μM. It becomes a promising probe for detecting and showing cellular imaging of GSH in MCF-7 cells. The N-Ti3C2 QDs/Fe3+ nanoprobe might provide a new way for imaging-guided precision cancer diagnosis.Inorganic-enzyme composites have been widely used for applications in catalysis and analytical science. Amorphous calcium phosphate, as a biocompatible material, can form open hydrated structure to encapsulate and protect enzymes. So far, there have been few progress on size-adjustable amorphous calcium phosphate nanoparticles since the diameter controllability is limited by its natural aggregation characteristics. By co-precipitation and nano-channel extrusion, we developed enzyme-loaded amorphous calcium phosphate nanoparticles with adjustable diameters. These enzyme-loaded particles showed high thermal and chemical stability as well as biocompatibility. The nano-sized enzyme-loaded particles can further expand their application fields and be used as intracellular enzyme probes. Delivering glucose oxidase enzyme by amorphous calcium phosphate nanoparticles enables fluorescent monitoring of glucose levels in living cells, which can be used to study the metabolism rates of cancer cells and normal cells. The nano-channel extrusion method can also be used as a template to encapsulate different kinds of enzymes to expand catalysis and biosensing applications.
  To describe the epidemiology and health resource utilization for convulsive status epilepticus (SE) in the emergency department (ED).
 
  Retrospective descriptive study in the Nationwide Emergency Department Sample (NEDS). Primary SE and secondary SE (SE in a case who visited the ED for other primary reason) were compared with non-SE seizures. Secondary SE is expected to have worse outcomes and higher costs because of another primary cause for ED visit.
 
  In the period 2010-2014, there were 149,750 ED visits with primary SE; 83,459 ED with secondary SE; and 5,359,103 ED visits with non-SE seizures. On multivariable analysis adjusting for potential confounders, the odds of hospital admission were 7 times higher for primary SE than for non-SE seizures, and 5 times higher for secondary SE than for non-SE seizures; the odds of transfer to another hospital were 9 times higher for primary SE than for non-SE seizures, and 3 times higher for secondary SE than for non-SE seizures; the odds of death were 2.5 times higher for primary SE than for non-SE seizures, and 12 times higher for secondary SE than for non-SE seizures; and the charges (in January 2020 USA dollars) were $9000 higher in primary SE than in non-SE seizures, and $35,000 higher in secondary SE than in non-SE seizures.